BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34342021)

  • 1. Development and preliminary evaluation of the Neurofibromatosis Type 1 Adult Quality of Life (NF1-AdQoL) questionnaire.
    Crawford H; North K; Wilson MJ; Berman Y; McKelvey-Martin V; Morrison PJ; Fleming J; Barton B
    Clin Exp Dermatol; 2022 Feb; 47(2):271-281. PubMed ID: 34342021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of life in individuals with neurofibromatosis type 1 associated cutaneous neurofibromas: validation of the Dutch cNF-Skindex.
    Dhaenens BAE; van Dijk SA; Fertitta L; Taal W; Wolkenstein P; Oostenbrink R
    J Patient Rep Outcomes; 2024 May; 8(1):52. PubMed ID: 38811427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life in neurofibromatosis 1: development and validation of a tool dedicated to cutaneous neurofibromas in adults.
    Fertitta L; Bergqvist C; Armand ML; Moryousef S; Ferkal S; Jannic A; Ravaud P; Tran VT; Ezzedine K; Wolkenstein P
    J Eur Acad Dermatol Venereol; 2022 Aug; 36(8):1359-1366. PubMed ID: 35412677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of the adult PedsQL™ neurofibromatosis type 1 module: initial feasibility, reliability and validity.
    Nutakki K; Hingtgen CM; Monahan P; Varni JW; Swigonski NL
    Health Qual Life Outcomes; 2013 Feb; 11():21. PubMed ID: 23432799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of quality of life in adults with neurofibromatosis 1 (NF1) using the Impact of NF1 on Quality Of Life (INF1-QOL) questionnaire.
    Ferner RE; Thomas M; Mercer G; Williams V; Leschziner GD; Afridi SK; Golding JF
    Health Qual Life Outcomes; 2017 Feb; 15(1):34. PubMed ID: 28193237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of neurofibromatosis type 1 on quality of life using the Skindex-29 questionnaire quality of life in NF1.
    Cieza Rivera AM; Lobato Fuertes C; Fernández-Villa T; Martín Sánchez V; Atallah I
    Orphanet J Rare Dis; 2024 Feb; 19(1):85. PubMed ID: 38402381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The reliability and validity of Chinese version of SF36 v2 in aging patients with chronic heart failure.
    Dong A; Chen S; Zhu L; Shi L; Cai Y; Zeng J; Guo W
    Aging Clin Exp Res; 2017 Aug; 29(4):685-693. PubMed ID: 27518815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and psychometric validation of the Chinese version of Skindex-29 and Skindex-16.
    He Z; Lu C; Chren MM; Zhang Z; Li Y; Ni X; Buchtel V HA; Ryan PF; Li GZ
    Health Qual Life Outcomes; 2014 Dec; 12():190. PubMed ID: 25539748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related quality of life in young adults in education, employment, or training: development of the Japanese version of Pediatric Quality of Life Inventory (PedsQL) Generic Core Scales Young Adult Version.
    Kaneko M; Sato I; Soejima T; Kamibeppu K
    Qual Life Res; 2014 Sep; 23(7):2121-31. PubMed ID: 24526295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Survey on the applicability of SF-36 version-2 (SF-36v2) in assessment quality of life among urban residents in Chengdu city].
    Zhao L; Liu Z; He Y; Li N; Liu D
    Zhonghua Yu Fang Yi Xue Za Zhi; 2014 May; 48(5):370-4. PubMed ID: 24985375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Burden of adult neurofibromatosis 1: development and validation of a burden assessment tool.
    Armand ML; Taieb C; Bourgeois A; Bourlier M; Bennani M; Bodemer C; Wolkenstein P;
    Orphanet J Rare Dis; 2019 May; 14(1):94. PubMed ID: 31053133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The PlexiQoL, a patient-reported outcome measure on quality of life in neurofibromatosis type 1-associated plexiform neurofibroma: translation, cultural adaptation and validation into the Dutch language for the Netherlands.
    Dhaenens BAE; van Dijk SA; Taal W; Noordhoek DC; Coffey A; McKenna SP; Oostenbrink R
    J Patient Rep Outcomes; 2024 Mar; 8(1):33. PubMed ID: 38499890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysfunctional coping is related to impaired skin-related quality of life and psychological distress in patients with neurofibromatosis type 1 with major skin involvement.
    Bottesi G; Spoto A; Trevisson E; Zuccarello D; Vidotto G; Cassina M; Clementi M
    Br J Dermatol; 2020 Jun; 182(6):1449-1457. PubMed ID: 31329288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validity and reliability of the Italian version of the ECOS-16 questionnaire in postmenopausal women with prevalent vertebral fractures due to osteoporosis.
    Salaffi F; Malavolta N; Cimmino MA; Di Matteo L; Scendoni P; Carotti M; Stancati A; Mulé R; Frigato M; Gutierrez M; Grassi W;
    Clin Exp Rheumatol; 2007; 25(3):390-403. PubMed ID: 17631735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The French version of Skindex (Skindex-France). Adaptation and assessment of psychometric properties].
    Leplège A; Ecosse E; Zeller J; Revuz J; Wolkenstein P
    Ann Dermatol Venereol; 2003 Feb; 130(2 Pt 1):177-83. PubMed ID: 12671579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A disease-specific measure of health-related quality of life for use in adults with immune thrombocytopenic purpura: its development and validation.
    Mathias SD; Bussel JB; George JN; McMillan R; Okano GJ; Nichol JL
    Health Qual Life Outcomes; 2007 Feb; 5():11. PubMed ID: 17316442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and Validation of a Novel Generic Health-related Quality of Life Instrument With 20 Items (HINT-20).
    Jo MW; Lee HJ; Kim SY; Kim SH; Chang H; Ahn J; Ock M
    J Prev Med Public Health; 2017 Jan; 50(1):38-59. PubMed ID: 28173686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acromegaly Quality of Life Questionnaire (ACROQOL) a new health-related quality of life questionnaire for patients with acromegaly: development and psychometric properties.
    Webb SM; Prieto L; Badia X; Albareda M; Catalá M; Gaztambide S; Lucas T; Páramo C; Picó A; Lucas A; Halperin I; Obiols G; Astorga R
    Clin Endocrinol (Oxf); 2002 Aug; 57(2):251-8. PubMed ID: 12153605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of health concerns in people with neurofibromatosis type 1.
    Fleming J; Morgan O; Wong C; Schlub TE; Berman Y
    Mol Genet Genomic Med; 2023 Jan; 11(1):e2077. PubMed ID: 36444392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement properties of Skindex-16: a brief quality-of-life measure for patients with skin diseases.
    Chren MM; Lasek RJ; Sahay AP; Sands LP
    J Cutan Med Surg; 2001; 5(2):105-10. PubMed ID: 11443481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.